ALPN
Alpine Immune Sciences Inc
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
63 hedge funds and large institutions have $251M invested in Alpine Immune Sciences Inc in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
Holders
63
Holding in Top 10
3
Calls
$8K
Puts
$1K
Top Buyers
| 1 | +$3.74M | |
| 2 | +$1.75M | |
| 3 | +$1.72M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.39M |
| 5 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
+$1.34M |
Top Sellers
| 1 | -$48.3M | |
| 2 | -$924K | |
| 3 | -$720K | |
| 4 |
Walleye Capital
New York
|
-$514K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$508K |